Lack of effect of a glycine(B) receptor partial agonist on amphetamine-induced sensitization in mice

Polish Journal of Pharmacology

Volumn 51, Issue 5, 1999, Pages 385-390

  Przegaliński, Edmund ^a   Siwanowicz, Joanna ^a   Chojnacka Wójcik, Ewa ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 aminocyclopropanecarboxylic acid; Amphetamine; Glycine(B) receptors; Mice; Sensitization

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; AMPHETAMINE; GLYCINE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; SENSITIZATION;

AMINO ACIDS; AMINO ACIDS, CYCLIC; AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0344339741     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bristow L. J., Flatman K. L., Hutson P. H., Kulagowski J. J., Leeson P. D., Young L., Tricklebank M. D.: The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist L-701,324, in rodents. J. Pharmacol. Exp. Ther., 1993, 108, 1156-1163.
2. Haracz J. L., Belanger S. A., MacDonall J. S., Sircar R.: Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci., 1995, 57, 2347-2357.
3. Ida I., Asami T., Kuribara H.: Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn. J. Pharmacol., 1995, 69, 83-90.
4. Kalivas P. W., Stewart J.: Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev., 1991, 16, 223-244.
5. Karler R., Calder L. D., Chaudhry I. A., Turkanis S. A.: Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci., 1989, 45, 599-606.
6. Karler R., Chaudhry I. A., Calder L. D., Turkanis S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res., 1990, 537, 76-82.
7. Kim H. S., Park W. K., Jang C. G.: Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull., 1996, 40, 201-207.
8. Kretschmer B. D., Bubser M., Schmidt W. J.: Behavioral and neurochemical actions of strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats. Eur. J. Pharmacol., 1995, 280, 37-45.
9. Kuribara B. K., Uchihashi Y.: Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J. Pharm. Pharmacol., 1993, 45, 1042-1045.
10. Lieberman J. A., Sheitman B. B., Kinon B. J.: Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology, 1997, 17, 205-229.
11. Marvizon J. C. G., Lewin A. H., Skolnick P.: 1-Amino-cyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of N-methyl-D-aspartate receptor complex. J. Neurochem., 1989, 52, 992-994.
12. Morrow B. A., Clark W. A., Roth R. H.: Stress activation of mesocorticolimbic dopamine neurons: effect of a glycine/NMDA receptor antagonist. Eur. J. Pharmacol., 1993, 238, 255-262.
13. Morrow B. A., Taylor J. R., Roth R. H.: R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. Brain Res., 1995, 673, 165-169.
14. Pierce R. C., Kalivas P. W.: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev., 1997, 25, 192-216.
15. Przegaliński E., Tatarczyńska E., Dereń-Wesołek A., Chojnacka-Wójcik E.: Anticonflict effects of competitive NMDA receptor antagonist and partial agonist at strychnine-insensitive glycine receptors. Pharmacol. Biochem. Behav., 1996, 54, 73-77.
16. Przegaliński E., Tatarczyńska E., Deren-Wesolek A., Chojnacka-Wójcik E.: Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology, 1997, 36, 31-37.
17. B receptors. Pharmacol. Biochem. Behav., 1999, in press.
18. Robinson T. E., Becker J. B.: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev., 1986, 11, 157-198.
19. Robinson T. E., Berridge K. C.: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev., 1993, 18, 247-291.
20. Skolnick P., Marvizon J. C. S., Jackson B. W., Monn J. A., Rice K. C., Lewin A. H.: Blockade of N-methyl-D-aspartate-induced convulsions by I-aminocyclopropane carboxylates. Life Sci., 1989, 45, 1647-1655.
21. Stewart J, Druhan J. P.: Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology, 1993, 110, 125-132.
22. Thomson A. M.: Glycine is a coagonist at the NMDA receptor/channel complex. Prog. Neurobiol., 1990, 35, 53-74.
23. Trulas R., Skolnick P.: Functional antagonists at the NMDA receptor complex exhibit antidepressant action. Eur. J. Pharmacol., 1990, 185, 1-10.
24. Vesina P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res., 1993, 605, 332-337.
25. Wolf M. E., Jeziorski M.: Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res., 1993, 613, 291-294.
26. Wolf M. E., Khansa M. R.: Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res., 1991, 562, 164-168.